Eli Lilly Slams Bid To Dredge Up Zyprexa Past In Actos Row

Law360, New York (March 18, 2014, 8:32 PM EDT) -- Eli Lilly & Co. argued in Louisiana district court Monday that the Actos bellwether trial plaintiffs are seeking extreme sanctions over a former executive’s testimony on a different drug — one which the drugmaker copped to a criminal charge for in 2009 — simply to tarnish its image with the jury.

The plaintiffs are seeking a default judgment against Eli Lily over testimony “irrelevant” to its diabetes drug Actos — which the plaintiffs claim causes bladder cancer — just to dredge up the drugmaker's former troubles...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Allen et al v. Takeda Pharmaceuticals North America Inc et al


Case Number

6:12-cv-00064

Court

Louisiana Western

Nature of Suit

Personal Inj. Prod. Liability

Judge

Rebecca F Doherty

Date Filed

January 17, 2012


Case Title

In Re: Actos (Pioglitazone) Products Liability Litigation


Case Number

6:11-md-02299

Court

Louisiana Western

Nature of Suit

Personal Inj. Prod. Liability

Judge

Rebecca F Doherty

Date Filed

December 29, 2011

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.